BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of Bv100 in China

Ad hoc announcement pursuant to Art. 53 LR BASEL, Switzerland, Nov. 06, 2025 (GLOBE NEWSWIRE) -- First healthy volunteer dosed with BV100 in China in mandatory Phase 1 trialInclusion of Chinese ...